Registry of recovery outcomes after bladder cancer surgery
Measuring Surgical Recovery After Radical Cystectomy
This study is creating a registry to track how patients recover after bladder cancer surgery to see how well different treatments work.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 11 sites (San Francisco, California and 10 other locations) |
| Trial ID | NCT03193970 on ClinicalTrials.gov |
What this trial studies
This study aims to create a registry that tracks post-surgical outcomes for patients undergoing radical cystectomy for bladder cancer at MD Anderson Cancer Center and its collaborating institutions. It focuses on collecting detailed baseline data on patient-reported and clinician-reported outcomes, as well as various presenting conditions. The information gathered will be used to evaluate the effectiveness of future quality improvement interventions in enhancing patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with bladder cancer who are scheduled to undergo radical cystectomy.
Not a fit: Patients who are not undergoing radical cystectomy or those with other unrelated conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could lead to improved recovery protocols and better overall outcomes for bladder cancer patients post-surgery.
How similar studies have performed: Other studies have successfully established similar registries to improve surgical outcomes, indicating that this approach has been effective in the past.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Bladder cancer patients undergoing radical cystectomy at the MD Anderson Cancer Center and the collaborating centers. Exclusion Criteria: N/A
Where this trial is running
San Francisco, California and 10 other locations
- University of California - San Francisco — San Francisco, California, United States (Recruiting)
- Stanford University — Stanford, California, United States (Not_yet_recruiting)
- Emory University — Atlanta, Georgia, United States (Recruiting)
- University of Chicago — Chicago, Illinois, United States (Recruiting)
- University of Kansas Medical Center — Lawrence, Kansas, United States (Recruiting)
- John Hopkins Medical Institutions — Baltimore, Maryland, United States (Recruiting)
- Spectrum Health Medical Group — Grand Rapids, Michigan, United States (Not_yet_recruiting)
- Winthrop University Hospital — Mineola, New York, United States (Not_yet_recruiting)
- University of Rochester — Rochester, New York, United States (Recruiting)
- University of Texas - Southwestern — Dallas, Texas, United States (Recruiting)
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Neema Navai, MD — M.D. Anderson Cancer Center
- Study coordinator: Neema Navai, MD
- Email: nnavai@mdanderson.org
- Phone: 713-792-3950
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.